AI & Diagnostics Software in New Jersey

Balchem Corporation is a specialty ingredients company founded in 1967, operating three business segments: Human Nutrition & Health (HNH), Animal Nutrition & Health (ANH), and Specialty Products. The HNH segment develops science-based nutritional ingredients including chelated minerals, vitamin K2, methylsulfonylmethane, and choline formulations targeting cognitive function and bone health. The ANH segment provides choline chloride and encapsulated nutrients for ruminants, monogastrics, and companion animals, leveraging proprietary encapsulation and spray-drying technologies. The Specialty Products segment includes Performance Gases for medical device sterilization and packaging applications, plus Metalosate® chelated minerals for agricultural markets. Balchem operates eight Innovation Centers globally and emphasizes custom ingredient development, bioavailability enhancement, and R&D-driven product innovation across human health, animal nutrition, and food production markets.

JOGO Health is a digital therapeutics company specializing in FDA-registered Class II EMG biofeedback systems for pain and neuromuscular disorder management. The platform integrates wearable sensors with advanced AI to leverage neuroplasticity, delivering non-invasive, medication-free virtual rehabilitation. Founded on research by Dr. Joseph Brudny (NYU) and Dr. Gordon Silverman (Rockefeller University), JOGO combines Electromyography biofeedback, Pain Neuroscience Education, Pain Reprocessing Therapy, and physical therapy. Clinical trials at Brigham and Women's Hospital (Harvard) and Mayo Clinic demonstrated superior outcomes versus opioids for chronic pain and superiority over standard care for neuromuscular disorders. The platform enables hybrid or fully virtual tele-rehabilitation, allowing home-based therapy. Medicare and major commercial payers cover JOGO for migraine, tension-type headache, cancer pain, urinary incontinence, pelvic pain, fecal incontinence, chronic constipation, stroke recovery, and neurorehabilitation. Indicated conditions include Parkinson's, Essential Tremor, cerebral palsy, Bell's palsy, spinal cord injury, and multiple sclerosis.

Sebia Autoimmune & Infectious Diseases (formerly ZEUS Scientific) is a US-based in vitro diagnostic (IVD) company with 45+ years of clinical diagnostics expertise. Founded in 1976 and acquired by Sebia in October 2022, the company develops, manufactures, and markets high-quality immunoassays for autoimmune disorders and infectious diseases. ZEUS Scientific offers a portfolio of over 125 FDA-cleared assays utilizing Indirect Fluorescent Antibody (IFA) and Enzyme Immunoassay (EIA) technologies. Key products include automated IFA slide processing systems and digital immunofluorescence imaging solutions. The company provides comprehensive contract manufacturing, OEM partnerships, and custom diagnostic solutions. With deep expertise in immunofluorescence imaging, flow cytometry, and clinical protein electrophoresis, ZEUS Scientific supports hospital laboratories, clinical research organizations, and diagnostic manufacturers globally with workflow automation and quality assurance.